Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia
Khalid H. Alanazi, Glen R. Abedi
, Claire M. Midgley, Abdulrahim Alkhamis, Taghreed Alsaqer, Abdullah Almoaddi, Abdullah Algwizani, Sameeh S. Ghazal, Abdullah M. Assiri, Hani Jokhdar, Susan I. Gerber, Hail Alabdely, and John T. Watson
Author affiliations: Ministry of Health, Riyadh, Saudi Arabia (K.H. Alanazi, A. Alkhamis, T. Alsaqer, A. Almoaddi, A. Algwizani, S.S. Ghazal, A.M. Assiri, H. Jokhdar, H. Alabdely); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (G.R. Abedi, C.M. Midgley, S.I. Gerber, J.T. Watson)
Figure. Characteristics of 32 case-patients infected with Middle East respiratory syndrome coronavirus, by underlying condition and survival status, Saudi Arabia. 1, DM defined as hyperglycemia recorded during hospitalization (n = 2). 2a, chronic lung disease in 1 patient with no DM or HTN who survived, 1 patient with DM and HTN but no COD who died, and 1 patient with CVD and not CKD who died. 2b, epilepsy in 1 patient with CVD and CKD who died. 2c, uterine cancer in 1 patient with CVD and not CKD who died. COD, chronic organ damage; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension.
Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.